Published: December 15, 2016
Authors: J. V. Reynolds, National Lead for Oesophagogastric Cancer in Ireland
Three papers are published in the December 2016 issue, which discuss the national registries for oesophagogastric cancer in the Netherlands, Sweden and Japan and take a broad look at what treatment paths are most successful. Professor John Reynolds, National Lead for Oesophagogastric Cancer in Ireland, discusses the findings of each paper.
Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. Br J Surg 2016; 103: 1855-1863. Free access.
Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry. Br J Surg 2016; 103: 1864-1873. Read here.
Impact of hospital volume on risk-adjusted mortality following oesophagectomy in Japan. Br J Surg 2016; 103: 1880-1886. Read here.